In breast cancer, high ASS1 is associated with increased purine synthesis, potentially sensitizing cells to mizoribine (45), an immunosuppressive drug used in renal transplantation; however, in MPM we found no link between mizoribine sensitivity and either ASS1 or BAP1 status. Here, ASS1 is linked to breast carcinoma.